GoHealth, Inc.
GOCO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $799 | $735 | $632 | $1,062 |
| % Growth | 8.7% | 16.3% | -40.5% | – |
| Cost of Goods Sold | $131 | $159 | $188 | $239 |
| Gross Profit | $668 | $576 | $444 | $823 |
| % Margin | 83.7% | 78.4% | 70.3% | 77.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $82 | $93 | $117 | $98 |
| SG&A Expenses | $318 | $298 | $324 | $463 |
| Sales & Mktg Exp. | $236 | $205 | $208 | $365 |
| Other Operating Expenses | $358 | $359 | $439 | $849 |
| Operating Expenses | $675 | $657 | $763 | $1,313 |
| Operating Income | -$7 | -$82 | -$319 | -$489 |
| % Margin | -0.9% | -11.1% | -50.4% | -46.1% |
| Other Income/Exp. Net | $2 | -$69 | -$57 | -$45 |
| Pre-Tax Income | -$5 | -$151 | -$376 | -$534 |
| Tax Expense | $2 | $0 | $1 | -$0 |
| Net Income | -$3 | -$63 | -$149 | -$189 |
| % Margin | -0.4% | -8.6% | -23.5% | -17.8% |
| EPS | -0.66 | -7.19 | -17.72 | -26.85 |
| % Growth | 90.8% | 59.4% | 34% | – |
| EPS Diluted | -0.66 | -7.19 | -17.72 | -26.85 |
| Weighted Avg Shares Out | 10 | 9 | 8 | 7 |
| Weighted Avg Shares Out Dil | 10 | 9 | 8 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $73 | $69 | $57 | $34 |
| Depreciation & Amortization | $106 | $106 | $107 | $108 |
| EBITDA | $174 | $24 | -$212 | -$393 |
| % Margin | 21.7% | 3.3% | -33.5% | -37% |